Double agent
Anti-CD47 cancer treatment has been found to help atherosclerosis
Anti-CD47 cancer treatment has been found to help atherosclerosis
Keeping joint movement pain-free
Stanford launched its own test early in the pandemic — but the challenges kept on coming
Ulcerative colitis patients could be missing a key intestinal microbe
A sampler of COVID-19 research
Stanford researchers stand at the forefront of efforts to defeat the disease
Stimulating cells that jump in to protect healthy tissues in MS patients when their immune systems attack could lead to new drug therapies, researcher says.
The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.
Scientists have devised a blood-based test that accurately identified people with chronic fatigue syndrome, a new study reports.
Surgeon performs Stanford Medicine’s first scar-free thyroid removal.